In addition, DNA minor groove‐binding agents in DNA, such as trabectedin or mithramycin, have been described as potent inhibitors of EWSR1‐FLI1‐mediated transcription with anti‐tumor potential (Bailey et al, 2019; Harlow et al, 2019). Here, EWSR1 is linked to neoplasm.